The clinical features of two patients with vitreous hemorrhage secondary to age-related macular degeneration and the histopathological findings in one of these cases are reported. Twenty additional cases are reviewed and compared with previously reported series. In patients with vitreous hemorrhage secondary to age-related macular degeneration, the appearance of vitreal blood is often preceded by extensive subretinal hemorrhage. Although this condition may be confused with a vitreous hemorrhage accompanying choroidal malignant melanoma, the correct diagnosis is usually apparent from clinical findings and ultrasonography. In most patients the prognosis for visual improvement is poor because of macular degeneration and extensive subretinal hemorrhage. A vitrectomy to remove the vitreous hemorrhage associated with macular degeneration is rarely beneficial.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0039-6257(87)90104-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A pilot randomized controlled trial evaluating haemostasis with fibrin glue during surgery for proliferative diabetic retinopathy.
Am J Ophthalmol
January 2025
Indian Health Outcomes, Public Health, and Economics Research Center, L V Prasad Eye Institute, Hyderabad, Telangana, India; Anant Bajaj Retina Institute, L V Prasad Eye Institute, Hyderabad, Telangana, India. Electronic address:
Purpose: To evaluate the safety and efficacy of fibrin glue in preventing early recurrence of vitreous haemorrhage following surgery for proliferative diabetic retinopathy (PDR).
Design: Single masked randomized-controlled clinical trial SUBJECTS: Consecutive patients with vitreous haemorrhage due to PDR undergoing primary vitreoretinal surgery were screened. After completing all vitreoretinal manoeuvres including endo-cautery to bleeders, infusion pressure was gradually reduced to 5 mmHg.
Eales' Disease in Inuit: A Short Report and Clinical Update.
Int Med Case Rep J
January 2025
Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup, Denmark.
Purpose: We report a case of Eales disease in Inuit and reflect on advances in telemedicine and treatment of retinal disease since the first report of Eales' disease in Greenlandic Inuit was published.
Patients And Methods: A 41-year-old Inuit female complaining of blurred vision was referred to our eye department. There had been no sign of diabetic retinopathy during diabetic eye screening and the patient had been treated for tuberculosis in 2010.
Evaluation of a modified sutureless technique for scleral fixation of one-piece posterior chamber intraocular lens: a retrospective study.
Front Med (Lausanne)
January 2025
Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Article Synopsis
- This study evaluates a new method for securing a posterior chamber intraocular lens (PCIOL) in patients who have lost their natural lens, focusing on outcomes one year post-surgery.
- The research involved a review of 45 patients, showing significant improvements in both uncorrected and best-corrected vision after the procedure, alongside some minor postoperative complications.
- Overall, the results suggest that this modified technique is effective for stabilizing PCIOLs in aphakic eyes over the long term.
The "Triangle" Sign: A Novel Ultrasound Marker for Diagnosing Total Choroidal Detachment and Total Suprachoroidal Hemorrhage.
Clin Ophthalmol
January 2025
University Eye Clinic Maastricht, Maastricht, the Netherlands.
Purpose: This study aims to explore the diagnostic utility of ultrasound B-scan while introducing the "Triangle" sign as a novel indicator. It also validates the sign's efficacy in distinguishing between choroidal detachment (CD) and suprachoroidal hemorrhage (SCH) from retinal detachment (RD) and vitreous hemorrhage (VH).
Patients And Methods: Retrospective analysis of consecutive cases of total CD and SCH undergoing B-scan at a single tertiary imaging center.
A meta-analysis of intravitreal ranibizumab versus laser photocoagulation for the treatment of retinopathy of prematurity.
Ophthalmol Retina
January 2025
Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Canada; John and Liz Tory Eye Centre, Sunnybrook Health Sciences Centre, Toronto, Canada. Electronic address:
Purpose: Laser photocoagulation (LPC) has been a traditional treatment for retinopathy of prematurity (ROP). However, intravitreal anti-VEGF agents such as bevacizumab and ranibizumab (IVR) have also been increasingly used. This meta-analysis aims to rigorously compare IVR to LPC in the treatment of ROP.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!